Insider Trading: Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

6.67USD
1 May 2015
Change (% chg)

$0.10 (+1.52%)
Prev Close
$6.57
Open
$6.63
Day's High
$6.83
Day's Low
$6.51
Volume
582,137
Avg. Vol
1,157,084
52-wk High
$9.37
52-wk Low
$3.12

Search Stocks
DP VII ASSOCIATES L P

Institutional Holders

% Shares Owned: 90.49%
# of Holders: 188
Total Shares Held: 113,099,976
3 Mo. Net Change: 821,950
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 11
# Reduced Positions: 8
# Net Buyers: 3

Officers & Directors

Name Age Since Current Position

Eckard Weber

64 2009 Independent Chairman of the Board

Michael Narachi

54 2009 President, Chief Executive Officer, Director

Joseph Hagan

45 2011 Acting Chief Financial Officer, Treasurer, Chief Business Officer

Heather Turner

41 2010 Senior Vice President, General Counsel, Secretary

Preston Klassen

45 2009 Senior Vice President, Head of Global Development

Mark Booth

54 2009 Chief Commercial Officer

Louis Bock

50 2005 Independent Director

Wendy Dixon

59 2010 Independent Director

Brian Dovey

73 2004 Independent Director

David Endicott

50 2012 Independent Director

Peter Honig

57 2010 Independent Director

Patrick Mahaffy

51 2009 Independent Director

Lota Zoth

55 2012 Independent Director
Search Stocks